📰 Abelacimab Phase News
Abelacimab Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abelacimab Phase. Real-time updates on events, politics, business and more.
June 8, 2023
Fewer than 26% of Chinese Patients with Atrial Fibrillation are Prescribed an Anticoagulant, while in Japan Almost One-Third of Patients are Undertreated ...
September 13, 2022
Anthos Therapeutics has announced that Abelacimab has received FDA Fast Track Designation for the prevention of stroke and systemic embolism in patients with atrial fibrillation.
May 6, 2022
Abelacimab: First Factor XI Inhibitor to Enroll Patients in a Phase 3 Clinical Trial - read this article along with other careers information, tips and advice on BioSpace
May 5, 2022
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and metabolic diseases, today...
May 5, 2022
/PRNewswire/ -- Anthos Therapeutics, a clinical-stage biopharma company developing innovative therapies for cardiovascular and metabolic diseases, today...